Regeneron Pharmaceuticals (REGN)
Net Income Growth
-2.91%
TTM · Period ending:
REGN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-2.91%period ending
Latest reported-2.91%period ending
REGN TTM Net Income YoY % (-33.33% → -2.91%)
Year-over-year change
High-resolution chart · PNG
REGN net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -2.9135% | |
| -1.6869% | |
| 2.0917% | |
| -1.6436% | |
| 3.1677% | |
| 16.6286% | |
| 11.6097% | |
| 16.622% | |
| 0.528% | |
| -7.7677% | |
| -8.8696% | |
| -25.682% | |
| -24.4039% | |
| -47.2787% | |
| -46.2757% | |
| -23.2321% | |
| -8.3572% | |
| 98.1518% | |
| 129.856% | |
| 121.6572% | |
| 107.9906% | |
| 75.6592% | |
| 66.0459% | |
| 47.1878% | |
| 44.1823% | |
| -6.1076% | |
| -13.4446% | |
| 19.2835% | |
| 30.0414% | |
| 70.0501% | |
| 103.957% | |
| 40.6428% | |
| 37.8171% | |
| 48.2304% | |
| 36.2141% | |
| 63.4926% | |
| 58.7407% | |
| 32.6959% | |
| 38.3326% | |
| 32.2229% | |
| 57.9264% | |
| 102.3608% | |
| 82.7359% | |
| 76.645% | |
| 16.2179% | |
| -8.257% | |
| -17.9771% | |
| -58.0552% | |
| -53.2746% | |
| -53.3212% | |
| -43.4387% | |
| 252.4276% | |
| 3,193.766% | |
| 602.5093% | |
| 438.3248% | |
| 223.7844% | |
| 82.2476% | |
| -41.9693% | |
| -112.2755% | |
| -44.7563% | |
| -65.1594% | |
| -41.4987% | |
| -49.4043% | |
| -94.5437% | |
| -9.9327% | |
| 6.3326% | |
| 15.46% | |
| -1.0722% | |
| -7.6798% | |
| -1.457% | |
| 21.6761% | |
| 47.9652% | |
| 31.3595% | |
| 21.9649% | |
| -3.1885% | |
| -22.2312% | |
| -6.2726% | |
| -0.1531% | |
| -7.2198% | |
| -60.4236% | |
| -174.7805% | |
| -314.3901% | |
| -328.8928% | |
| -422.4885% | |
| -1,329.1329% | |
| -145.4786% | |
| 139.4791% | |
| 116.0162% | |
| 102.5174% | |
| 91.4904% | |
| 15.0784% | |
| -4.1662% | |
| -22.2487% | |
| -45.6653% | |
| -63.2673% | |
| -103.441% | |
| -155.2044% | |
| -206.1727% | |
| -228.1499% | |
| -286.8042% |